title: Molecular docking cannot accurately predict drug off-target effects: implications for the role of voriconazole in the exacerbation of myasthenia gravis.
authors.affiliation: Biovista, Inc., Charlottesville, Virginia.
authors.forename: Spyros N
authors.initials: SN
authors.lastname: Deftereos
mesh_terms: D000935:Antifungal Agents / Q000009:adverse effects*; D001763:Blepharoptosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000150:complications*; D009886:Ophthalmoplegia / Q000139:chemically induced*; D011743:Pyrimidines / Q000009:adverse effects*; D014230:Triazoles / Q000009:adverse effects*
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles